| Non-Small Cell Lung Cancer |
1 |
1 |
| Lung Cancer |
0 |
0.9 |
| Platinum |
0 |
0.61 |
| Cardiac Resynchronization Therapy |
0 |
0.46 |
| Otolaryngology |
0 |
0.39 |
| Toxicology |
0 |
0.39 |
| Epidermal Growth Factor Receptor |
0 |
0.3 |
| Lung |
0 |
0.3 |
| Genomic Medicine |
0 |
0.29 |
| Small Cell Lung Cancer |
0 |
0.23 |
| Tyrosine Kinase Inhibitor |
0 |
0.22 |
| Biologic Therapy |
0 |
0.21 |
| COVID-19 |
0 |
0.21 |
| Thrombocytopenia |
0 |
0.2 |
| Acute Pain |
0 |
0.16 |
| Cancer |
0 |
0.15 |
| Chemotherapy |
0 |
0.15 |
| Cough |
0 |
0.15 |
| Food and Drug Administration (FDA) |
0 |
0.15 |
| Grant |
0 |
0.15 |
| Leukopenia |
0 |
0.15 |
| Nail |
0 |
0.15 |
| Pain |
0 |
0.15 |
| Receptors |
0 |
0.15 |
| Tumor |
0 |
0.15 |
| Tyrosine Kinase |
0 |
0.15 |
| Diarrhea |
0 |
0.13 |
| Neutropenia |
0 |
0.13 |
| Pain Management |
0 |
0.13 |